AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
NetApp sells Spot to Flexera for $100 million, four years after $450 million acquisition
2
Lenovo acquires enterprise storage company Infinidat in its first Israeli acquisition
3
Warburg Pincus Signs Deal to Acquire Israeli Credit Card Issuer for $680 Million
4
Spot.io founder nets $7 million Seed round to tackle cloud chaos with new startup
5
Global AI acquires Israeli AI startup Tectu for $13 million
More news

Biotech

20 stories about Biotech
נאסד"ק וול סטריט

Anchiano Therapeutics Stock Falls on Nasdaq IPO

13.02.19|Lilach Baumer
The cancer treatment company priced its ADSs at $11.5 per unit, expecting proceeds of $30.5 million
נאסדק

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19|Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19|Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
חברת תרופות סלג'ן סלג'ין Celgene משרדים סן דייגו קליפורניה

Celgene Backs Immunotherapy Company Biond Biologics

08.01.19|Meir Orbach
Biond develops immunotherapies for cancer and autoimmune diseases
אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies
חקר DNA מעבדה

Lonza Opens Israeli Innovation Center

20.11.18|Lilach Baumer
The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent
default image

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18|Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
default image

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
תל אביב קו רקיע Tel Aviv Skyline

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18|Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
מייקל היידן מחקר ו פיתוח טבע

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18|Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
נאסדק

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
קולפלנט דיו ביולוגי

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
נאסד"ק וול סטריט

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18|Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases
נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
נאסד"ק וול סטריט

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
MeMed בדיקת דם מימין ערן אדן ו כפיר עובד

Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering

20.09.18|Omer Kabir
The company will use the funding to launch a new model of its blood testing device, and to expand the range of tests it offers
רנטגן שניים

Antiseptic Materials Startup Nobio Raises $3.6 Million

30.07.18|Asaf Shalev
The Israel-based startup plans to target the dental and medical device industry, offering technology to solve the infection and contamination when devices are placed in the body.
בדיקת דם 1

Cancer Screening Company Nucleix Raises 2.5 Million Euros

30.07.18|Lilach Baumer
Founded in 2008, Nucleix develops urine and blood-based non-invasive, molecular cancer screening tests
מעבדה רפואה 1 זירת הבריאות

Eli Lilly Signs Multi-Year Collaboration with Anima Biotech

23.07.18|Lilach Baumer
Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones
Previous ArticlesMore Articles